Topics

F. Hoffmann-La Roche Ltd: China National Medical Products Administration grants approval of Roche's Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer

01:05 EST 14 Feb 2020 | FinanzNachrichten

This marks the first approval for a Tecentriq-based therapy in China, less than a year after the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals in this indicati...

Original Article: F. Hoffmann-La Roche Ltd: China National Medical Products Administration grants approval of Roche's Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer

NEXT ARTICLE

More From BioPortfolio on "F. Hoffmann-La Roche Ltd: China National Medical Products Administration grants approval of Roche's Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...